Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NUWIQ safely and effectively. See full prescribing information for NUWIQ. NUWIQ®, Antihemophilic Factor (Recombinant) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-other
NUWIQ is a recombinant antihemophilic factor [blood coagulation factor VIII (Factor VIII)] indicated in pediatric and adult patients with Hemophilia A for: On-demand treatment and control of bleeding episodes Perioperative management of bleeding Routine prophylaxis to reduce the frequency of bleeding episodes NUWIQ is not indicated for the treatment of von Willebrand disease.
- generic_name
- antihemophilic factor (recombinant)
- brand_name
- WATER
- product_names
- Antihemophilic Factor (Recombinant), WATER
- ndc
- 68982-151, 68982-151-01, 68982-152, 68982-152-01, 68982-901, 68982-901-01, 68982-149, 68982-149-01, 68982-150, 68982-150-01, 68982-147, 68982-147-01, 68982-148, 68982-148-01, 68982-145, 68982-145-01, 68982-146, 68982-146-01, 68982-153, 68982-153-01, 68982-154, 68982-154-01, 68982-143, 68982-143-01, 68982-144, 68982-144-01, 68982-141, 68982-141-01, 68982-142, 68982-142-01, 68982-139, 68982-139-01, 68982-140, 68982-140-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en